Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | REPL |
---|---|---|
09:32 ET | 12913 | 8.455 |
09:34 ET | 6945 | 8.555 |
09:36 ET | 732 | 8.52 |
09:38 ET | 1002 | 8.64 |
09:39 ET | 600 | 8.65 |
09:41 ET | 2700 | 8.61 |
09:43 ET | 200 | 8.57 |
09:48 ET | 1300 | 8.5 |
09:50 ET | 200 | 8.48 |
09:52 ET | 800 | 8.495 |
09:54 ET | 1300 | 8.54 |
09:57 ET | 1000 | 8.46 |
09:59 ET | 100 | 8.475 |
10:01 ET | 1026 | 8.48 |
10:03 ET | 200 | 8.5 |
10:08 ET | 200 | 8.5 |
10:10 ET | 6312 | 8.465 |
10:12 ET | 994 | 8.47 |
10:14 ET | 12410 | 8.42 |
10:15 ET | 509 | 8.45 |
10:17 ET | 2510 | 8.54 |
10:19 ET | 25500 | 8.53 |
10:21 ET | 2600 | 8.46 |
10:24 ET | 1333 | 8.38 |
10:26 ET | 4559 | 8.4 |
10:28 ET | 825 | 8.415 |
10:30 ET | 301 | 8.42 |
10:32 ET | 3980 | 8.45 |
10:33 ET | 1196 | 8.47 |
10:35 ET | 1525 | 8.47 |
10:37 ET | 1773 | 8.45 |
10:39 ET | 200 | 8.41 |
10:42 ET | 13300 | 8.41 |
10:44 ET | 300 | 8.43 |
10:46 ET | 4882 | 8.52 |
10:48 ET | 300 | 8.54 |
10:50 ET | 2795 | 8.4944 |
10:51 ET | 100 | 8.515 |
10:53 ET | 3434 | 8.54 |
10:55 ET | 586 | 8.58 |
10:57 ET | 2169 | 8.55 |
11:00 ET | 1100 | 8.56 |
11:02 ET | 1188 | 8.53 |
11:04 ET | 400 | 8.55 |
11:06 ET | 281 | 8.53 |
11:08 ET | 407 | 8.55 |
11:11 ET | 4039 | 8.5 |
11:13 ET | 1924 | 8.505 |
11:15 ET | 11978 | 8.425 |
11:18 ET | 4240 | 8.51 |
11:20 ET | 100 | 8.52 |
11:22 ET | 800 | 8.51 |
11:24 ET | 2000 | 8.52 |
11:26 ET | 700 | 8.5 |
11:27 ET | 1214 | 8.5 |
11:29 ET | 240 | 8.52 |
11:31 ET | 1000 | 8.505 |
11:33 ET | 1400 | 8.5 |
11:36 ET | 895 | 8.52 |
11:38 ET | 2427 | 8.51 |
11:40 ET | 2420 | 8.52 |
11:42 ET | 2278 | 8.53 |
11:44 ET | 1300 | 8.51 |
11:45 ET | 200 | 8.52 |
11:47 ET | 888 | 8.52 |
11:49 ET | 2563 | 8.515 |
11:51 ET | 836 | 8.52 |
11:54 ET | 300 | 8.53 |
11:56 ET | 30666 | 8.535 |
11:58 ET | 500 | 8.56 |
12:03 ET | 200 | 8.6 |
12:05 ET | 2462 | 8.64 |
12:07 ET | 100 | 8.64 |
12:09 ET | 1300 | 8.64 |
12:14 ET | 1300 | 8.63 |
12:18 ET | 4130 | 8.6 |
12:20 ET | 974 | 8.62 |
12:21 ET | 600 | 8.63 |
12:25 ET | 100 | 8.64 |
12:27 ET | 700 | 8.61 |
12:30 ET | 100 | 8.6 |
12:32 ET | 500 | 8.62 |
12:34 ET | 284 | 8.6 |
12:36 ET | 100 | 8.615 |
12:38 ET | 1883 | 8.67 |
12:39 ET | 600 | 8.66 |
12:41 ET | 2100 | 8.67 |
12:45 ET | 521 | 8.66 |
12:48 ET | 300 | 8.65 |
12:50 ET | 300 | 8.64 |
12:52 ET | 700 | 8.64 |
12:54 ET | 779 | 8.65 |
12:56 ET | 450 | 8.6583 |
12:57 ET | 500 | 8.66 |
12:59 ET | 500 | 8.66 |
01:01 ET | 600 | 8.63 |
01:03 ET | 27915 | 8.74 |
01:06 ET | 2513 | 8.76 |
01:08 ET | 725 | 8.76 |
01:10 ET | 5143 | 8.81 |
01:12 ET | 2683 | 8.845 |
01:14 ET | 300 | 8.84 |
01:15 ET | 2158 | 8.9 |
01:17 ET | 518 | 8.87 |
01:19 ET | 324 | 8.87 |
01:21 ET | 6175 | 8.86 |
01:24 ET | 6133 | 8.865 |
01:26 ET | 1200 | 8.865 |
01:28 ET | 4465 | 8.8599 |
01:30 ET | 1580 | 8.8 |
01:32 ET | 4783 | 8.74 |
01:33 ET | 2625 | 8.77 |
01:35 ET | 5326 | 8.82 |
01:37 ET | 2012 | 8.835 |
01:39 ET | 5574 | 8.835 |
01:42 ET | 600 | 8.845 |
01:44 ET | 857 | 8.87 |
01:46 ET | 1542 | 8.9 |
01:48 ET | 2464 | 8.88 |
01:50 ET | 1189 | 8.85 |
01:51 ET | 600 | 8.87 |
01:53 ET | 1925 | 8.845 |
01:55 ET | 600 | 8.845 |
01:57 ET | 1100 | 8.84 |
02:00 ET | 1797 | 8.8632 |
02:02 ET | 2204 | 8.85 |
02:04 ET | 1120 | 8.84 |
02:06 ET | 1190 | 8.84 |
02:08 ET | 2632 | 8.84 |
02:09 ET | 1312 | 8.86 |
02:11 ET | 1618 | 8.8854 |
02:13 ET | 1200 | 8.9 |
02:15 ET | 1962 | 8.9182 |
02:18 ET | 1300 | 8.93 |
02:20 ET | 554 | 8.94 |
02:22 ET | 1646 | 8.93 |
02:24 ET | 2471 | 8.91 |
02:26 ET | 100 | 8.91 |
02:27 ET | 8531 | 8.98 |
02:29 ET | 11994 | 8.9 |
02:31 ET | 757 | 8.88 |
02:33 ET | 950 | 8.885 |
02:36 ET | 2025 | 8.915 |
02:38 ET | 880 | 8.92 |
02:40 ET | 899 | 8.94 |
02:42 ET | 3764 | 8.9786 |
02:44 ET | 1023 | 8.95 |
02:45 ET | 600 | 8.95 |
02:47 ET | 1226 | 8.93 |
02:49 ET | 600 | 8.94 |
02:51 ET | 900 | 8.93 |
02:54 ET | 100 | 8.94 |
02:56 ET | 2175 | 8.9 |
02:58 ET | 5068 | 8.94 |
03:00 ET | 631 | 8.93 |
03:02 ET | 3800 | 8.89 |
03:03 ET | 4148 | 8.92 |
03:05 ET | 1116 | 8.9 |
03:07 ET | 700 | 8.92 |
03:09 ET | 100 | 8.93 |
03:12 ET | 1300 | 8.9 |
03:14 ET | 1316 | 8.885 |
03:16 ET | 623 | 8.88 |
03:18 ET | 2600 | 8.87 |
03:20 ET | 837 | 8.88 |
03:21 ET | 4178 | 8.88 |
03:23 ET | 600 | 8.88 |
03:25 ET | 1463 | 8.89 |
03:27 ET | 1152 | 8.89 |
03:30 ET | 3884 | 8.91 |
03:32 ET | 9804 | 8.92 |
03:34 ET | 2615 | 8.91 |
03:36 ET | 2342 | 8.91 |
03:38 ET | 3479 | 8.92 |
03:39 ET | 1800 | 8.91 |
03:41 ET | 602 | 8.91 |
03:43 ET | 14771 | 8.9 |
03:45 ET | 30641 | 8.97 |
03:48 ET | 4222 | 8.9 |
03:50 ET | 2553 | 8.905 |
03:52 ET | 17735 | 8.96 |
03:54 ET | 13908 | 8.92 |
03:56 ET | 17712 | 8.98 |
03:57 ET | 8118 | 8.99 |
03:59 ET | 27588 | 9 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Replimune Group Inc | 603.8M | -2.8x | --- |
Olema Pharmaceuticals Inc | 605.2M | -5.4x | --- |
GH Research PLC | 606.6M | -17.0x | --- |
Phathom Pharmaceuticals Inc | 602.9M | -2.3x | --- |
Cassava Sciences Inc | 592.5M | -10.6x | --- |
Lexicon Pharmaceuticals Inc | 607.2M | -2.0x | --- |
Replimune Group, Inc. a clinical-stage biotechnology company engaged in the development of a novel class of oncolytic immunotherapies. The Company’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. RP1 (vusolimogene oderparepvec) is its lead product candidate and is based on a proprietary strain of herpes simplex virus engineered and genetically armed with a fusogenic protein (GALV-GP R-) and GM-CSF intended to maximize tumor killing potency, the immunogenicity of tumor cell death, and the activation of a systemic anti-tumor immune response. It is also developing additional product candidates, RP2 and RP3, to enhance anti-tumor immune responses and are intended to address additional tumor types, including traditionally less immune responsive tumor types. RP2 additionally expresses an anti-CTLA-4 antibody-like molecule, as well as GALV-GP R- and GM-CSF.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $603.8M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 67.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.27 |
EPS | $-3.24 |
Book Value | $6.10 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.